Accelerate: Accelerate Diagnostics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2024

Accelerate Diagnostics, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 11.7 million compared to USD 12.06 million a year ago. Net loss was USD 50.05 million compared to USD 61.62 million a year ago. Basic loss per share from continuing operations was USD 2.15 compared to USD 4.94 a year ago. Diluted loss per share from continuing operations was USD 2.15 compared to USD 4.94 a year ago. Accelerate Diagnostics, Inc. reported earnings results for the full year ended December 31, 2024. For the full year, the company reported sales was USD 11.7 million compared to USD 12.06 million a year ago. Net loss was USD 50.05 million compared to USD 61.62 million a year ago. Basic loss per share from continuing operations was USD 2.15 compared to USD 4.94 a year ago. Diluted loss per share from continuing operations was USD 2.15 compared to USD 4.94 a year ago.